Predicting methadone maintenance treatment outcomes using the addiction severity index and the MMPI-2 content scales (negative treatment indicators and cynism scales)

American Journal of Drug and Alcohol Abuse

Volumn 30, Issue 4, 2004, Pages 823-839

  Craig, Robert J ^a   Olson, Ronald E ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

Addiction severity index; Methadone; Methadone maintenance; MMPI 2; Treatment outcome

Indexed keywords

ILLICIT DRUG; METHADONE;

ADDICTION; ADULT; ARTICLE; CONTROLLED STUDY; COUNSELING; CYNISM SCALE; DISCRIMINANT ANALYSIS; DISEASE SEVERITY; EMPLOYMENT; FOLLOW UP; HEALTH CARE; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; NEGATIVE TREATMENT INDICATOR; OPIATE ADDICTION; OUTPATIENT CARE; PREDICTION; RATING SCALE; SCORING SYSTEM; TREATMENT OUTCOME; URINALYSIS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; COMBINED MODALITY THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; HISPANIC AMERICANS; HUMANS; MALE; METHADONE; MIDDLE AGED; MMPI; OPIOID-RELATED DISORDERS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT DROPOUTS; PERSONALITY INVENTORY; PROGNOSIS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SOCIAL PERCEPTION;

EID: 9644265543     PISSN: 00952990     EISSN: None     Source Type: Journal    
DOI: 10.1081/ADA-200037548     Document Type: Article

References (32)

1. American Psychiatric Association. Position statement on methadone maintenance treatment. Am J Psychiatry 1994; 151:792-794.
2. Cooper JR, Altman F, Brown BS, Czechowicz D. Research on the Treatment of Narcotic Addiction: State of the Art. Rockville, MD: U.S. Department of Health and Human Service, National Institute on Drug Abuse, 1983.
3. Parrino MW. (Chair). State Methadone Treatment Guidelines. Center for Substance Abuse Treatment: Treatment Improvement Protocol (TIP) Series. Rockville, MD: Substance Abuse and Mental Health Services Administration, 1993.
4. Federal Regulation of Methadone Treatment. Rettig RA, Yarmolinsky A, eds. Washington, DC: Institute of Medicine. National Academy Press, 1995.
5. Ball JC, Ross A. The Effectiveness of Methadone Maintenance. New York: Springer-Verlag, 1991.
6. Hubbard RL. Drug Abuse Treatment: A National Study of Effectiveness. Chapel Hill, NC: University of North Carolina Press, 1989.
7. Maddux JF, Desmond DP. Methadone maintenance and recovery from opioid dependence. Am J Drug Alcohol Abuse 1992; 18:63-74.
8. Sells SB, Demaree RG, Hornick CW. Comparative Effectiveness of Drug Abuse Treatment Modalities. NIDA: Washington, DC, 1979.
9. Craig RJ. Personality dimensions related to premature termination from an inpatient drug abuse treatment program. J Clin Psychol 1984; 40:350-355.
10. Craig RJ. Can personality tests predict treatment dropouts? Int J Addict 1984; 19:665-674.
11. Aaronson LA, Dent OB, Kline CD. Cross-validation of MMPI and MMPI-2 predictor scales. J Clin Psychol 1996; 52:311-315.
12. Craig RJ. Assessing contemporary substance abusers with the MMPI. II. The MacAndrew Alcoholism Scale: a review. Subst Use Misuse. In press.
13. Butcher JN, Dahlstrom WG, Graham JR, Tellegen A, Kaemmer B. Minnesota Multiphasic Personality Inventory-2: Manual for Administration and Scoring. Minneapolis, MN: National Computer Systems, 1989.
14. Munley PH, Busby R. MMPI-2 negative treatment indicators scale and irregular discharge. Psychol Rep 1994; 74:903-906.
15. Haller DL, Knisely JS, Elswick RK, Dawson KS, Schnoll SH. Perinatal substance abusers: factors influencing treatment retention. J Subst Abuse Treat 1997; 14:513-519.
16. Gilmore JD, Lash SJ, Foster MA, Blosser SL. Adherence to substance abuse treatment: clinical utility of two MMPI-2 scales. J Pers Assm 2001; 77:524-540.
17. McLellan AT, Kushner H, Metzger DS, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9:199-213.
18. Rogalski CR. Factor structure of the Addiction Severity Index in an inpatient detoxification sample. Int J Addict 1987; 22:981-992.
19. Substance Abuse and Mental Health Services Administration. Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction: Final Rule. January 17, 2001, Federal Register. 21 CFR Part 291; 42 CFR Part 8. Wednesday. US Govt. Printing Press.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: APA, 1994.
21. Blaney T, Craig RJ. Methadone maintenance: does dose determine differences in outcome? J Subst Abuse Treat 1999; 16:221-228.
22. Craig RJ. Effectiveness of low-dose methadone maintenance for the treatment of inner city heroin addicts. Int J Addict 1980; 15:701-710.
23. General Accounting Office. Methadone Maintenance: Some Treatment Programs are Not Effective - Greater Federal Oversight Needed. Washington, DC: GAO, Human Resources Division, 1990.
24. Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Dose-response effects of methadone in the treatment of opioid dependence. Ann Intern Med 1993; 119:23-27.
25. Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Methadone dose and treatment outcome. Drug Alcohol Depend 1993; 33:105-117.
26. Ben-Porath YS, Sherwood NE. The MMPI-2 Content Component Scales: Development, Psychometric Characteristics and Clinical Application. Minneapolis, MN: University of Minnesota Press, 1993.
27. Craig RJ. Interpreting Personality Tests: A Clinical Manual for the MMPI-2, MCMI-III, CPI-R, and 16PF. New York: Wiley, 1999.
28. Mulvaney FD, Brown LS, Alterman AI, Sage RE, Cnaan A, Cacciola J, Rutherford M. Methadone-maintenance outcomes for Hispanic and African-American men and women. Drug Alcohol Depend 1989; 54:11-18.
29. Rogers R. Handbook of Diagnostic and Structured Interviewing. New York: Guilford, 2001.
30. Bovasso GB, Alterman AI, Cacciola JS, Cook TG. Predictive validity of the Addiction Severity Index's composite scores in the assessment of 2-year outcomes in a methadone maintenance population. Psychol Addict Behav 2001; 15:171-176.
31. McLellan AT, Childress AR, Griffith J, Woody GE. The psychiatrically severe drug abuse patient: methadone maintenance or therapeutic community? Am J Drug Alcohol Abuse 1984; 10:77-95.
32. McLellan AT, Luborsky L, Woody GE, O'Brien CP, Druley KA. Predicting response to alcohol and drug abuse treatments: role of psychiatric severity. Arch Gen Psychiatry 1983; 40:620-625.